Dr. Mikhail on Ongoing Trials in Multiple Myeloma

Sameh Mikhail, MD
Published: Friday, Dec 01, 2017



Sameh Mikhail, MD, medical oncologist, The Mark H. Zangmeister Cancer Center, discussing ongoing trials for patients with multiple myeloma.

According to Mikhail, many studies are looking at the inclusion of stem-cell transplants in patients with myeloma. Currently, there are many immune-modulatory agents and combinations that are being evaluated.

Immunotherapy continues to be an area of investigation in this patient population. Safety concerns are still being investigated, states Mikhail.
 


Sameh Mikhail, MD, medical oncologist, The Mark H. Zangmeister Cancer Center, discussing ongoing trials for patients with multiple myeloma.

According to Mikhail, many studies are looking at the inclusion of stem-cell transplants in patients with myeloma. Currently, there are many immune-modulatory agents and combinations that are being evaluated.

Immunotherapy continues to be an area of investigation in this patient population. Safety concerns are still being investigated, states Mikhail.
 

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Personalized Sequencing in Castration-Resistant Prostate Cancer: Bridging the Latest Evidence to the Bedside in Clinical ManagementAug 25, 20181.5
Community Practice Connections™: Medical Crossfire®: Translating Lessons Learned with PARP Inhibition to the Treatment of Breast Cancer—Expert Exchanges on Novel Strategies to Personalize CareAug 29, 20181.5
Publication Bottom Border
Border Publication
x